NCT00568633 2019-09-24
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Stanford University
Phase 3 Terminated
Clinical Trials
1 trialsLeukemia, Myeloid × Hematopoietic Stem Cell Transplantation × Other hematologic neoplasm × Clear all